Cargando…
Biological activities of fusarochromanone: a potent anti-cancer agent
BACKGROUND: Fusarochromanone (FC101) is a small molecule fungal metabolite with a host of interesting biological functions, including very potent anti-angiogenic and direct anti-cancer activity. RESULTS: Herein, we report that FC101 exhibits very potent in-vitro growth inhibitory effects (IC(50) ran...
Autores principales: | Mahdavian, Elahe, Palyok, Phillip, Adelmund, Steven, Williams-Hart, Tara, Furmanski, Brian D, Kim, Yoon-Jee, Gu, Ying, Barzegar, Mansoureh, Wu, Yang, Bhinge, Kaustubh N, Kolluru, Gopi K, Quick, Quincy, Liu, Yong-Yu, Kevil, Christopher G, Salvatore, Brian A, Huang, Shile, Clifford, John L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168212/ https://www.ncbi.nlm.nih.gov/pubmed/25187308 http://dx.doi.org/10.1186/1756-0500-7-601 |
Ejemplares similares
-
Fusarochromanone Induces G(1) Cell Cycle Arrest and Apoptosis in COS7 and HEK293 Cells
por: Gu, Ying, et al.
Publicado: (2014) -
Caspase-dependent signaling underlies glioblastoma cell death in response to the fungal metabolite, fusarochromanone
por: MAHDAVIAN, ELAHE, et al.
Publicado: (2014) -
Fusarochromanone-induced reactive oxygen species results in activation of JNK cascade and cell death by inhibiting protein phosphatases 2A and 5
por: Gu, Ying, et al.
Publicado: (2015) -
TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
por: Carroll, Natalie, et al.
Publicado: (2022) -
Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent
por: El-Saadi, Madison Wynne, et al.
Publicado: (2015)